Verdalles Úrsula, Goicoechea Marian, Garcia de Vinuesa Soledad, Quiroga Borja, Galan Isabel, Verde Eduardo, Perez de Jose Ana, Luño José
Departamento Nefrología, Hospital General Universitario Gregorio Marañón, Madrid, España.
Departamento Nefrología, Hospital General Universitario Gregorio Marañón, Madrid, España.
Nefrologia. 2016 Sep-Oct;36(5):523-529. doi: 10.1016/j.nefro.2016.04.003. Epub 2016 Jul 18.
Resistant hypertension (RH) is a common problem in patients with chronic kidney disease (CKD). A decline in the glomerular filtration rate (GFR) and increased albuminuria are associated with RH; however, there are few published studies about the prevalence of this entity in patients with CKD.
To estimate the prevalence of RH in patients with different degrees of kidney disease and analyse the characteristics of this group of patients.
A total of 618 patients with hypertension and CKD stages i-iv were enrolled, of which 82 (13.3%) met the criteria for RH.
RH prevalence increased significantly with age, the degree of CKD and albuminuria. The prevalence of RH was 3.2% in patients under 50 years, 13.8% between 50-79 years and peaked at 17.8% in patients older than 80 years. Renal function prevalence was 4, 15.8 and 18.1% in patients with an estimated glomerular filtration rate (GFR) of > 60, 30-59 and < 30ml/min/1.73 m, respectively, and 8.9, 15.9 and 22.5% for a urine albumin to creatinine ratio (UACR) < 30, 30-299 and > 300mg/g respectively. In a logistic regression model, the characteristics associated with resistant hypertension were age, history of cardiovascular disease, GFR, albuminuria and diabetes mellitus. A total of 47.5% of patients with resistant hypertension had controlled BP (<140/90mmHg) with 4 or more antihypertensive drugs. These patients were younger, with better renal function, less albuminuria and received more aldosterone antagonists.
RH prevalence increases with age, the degree of CKD and albuminuria. Strategies such as treatment with aldosterone receptor antagonists are associated with better blood pressure control in this group of patients, leading to reduced prevalence.
顽固性高血压(RH)是慢性肾脏病(CKD)患者中的常见问题。肾小球滤过率(GFR)下降和蛋白尿增加与RH相关;然而,关于CKD患者中该疾病患病率的已发表研究较少。
评估不同程度肾病患者中RH的患病率,并分析该组患者的特征。
共纳入618例高血压合并CKD Ⅰ - Ⅳ期患者,其中82例(13.3%)符合RH标准。
RH患病率随年龄、CKD程度和蛋白尿显著增加。50岁以下患者中RH患病率为3.2%,50 - 79岁患者中为13.8%,80岁以上患者中达到峰值17.8%。估计肾小球滤过率(GFR)>60、30 - 59和<30ml/min/1.73m²的患者中肾功能患病率分别为4%、15.8%和18.1%,尿白蛋白与肌酐比值(UACR)<30、30 - 299和>300mg/g的患者中分别为8.9%、15.9%和22.5%。在逻辑回归模型中,与顽固性高血压相关的特征为年龄、心血管疾病史、GFR、蛋白尿和糖尿病。共有47.5%的顽固性高血压患者使用4种或更多降压药物使血压得到控制(<140/90mmHg)。这些患者更年轻,肾功能更好,蛋白尿更少,且使用醛固酮拮抗剂更多。
RH患病率随年龄、CKD程度和蛋白尿增加。醛固酮受体拮抗剂治疗等策略与该组患者更好的血压控制相关,从而导致患病率降低。